Andere Kunden interessierten sich auch für
![Disability index in inflammatory bowel disease]( "Disability index in inflammatory bowel disease")
Disability index in inflammatory bowel disease16,99 €![Inflammatory Bowel disease in Systemic Lupus Erythematosus Patients]( "Inflammatory Bowel disease in Systemic Lupus Erythematosus Patients")
Inflammatory Bowel disease in Systemic Lupus Erythematosus Patients47,99 €![Inflammatory Bowel Disease Update]( "Inflammatory Bowel Disease Update")
Inflammatory Bowel Disease Update39,99 €![The Psychological Correction in Inflammatory bowel disease]( "The Psychological Correction in Inflammatory bowel disease")
The Psychological Correction in Inflammatory bowel disease18,99 €![ANEMIA AND CHRONIC INFLAMMATORY BOWEL DISEASE]( "ANEMIA AND CHRONIC INFLAMMATORY BOWEL DISEASE")
ANEMIA AND CHRONIC INFLAMMATORY BOWEL DISEASE29,99 €![INFLAMMATION MARKERS IN BOWEL SYNDROME]( "INFLAMMATION MARKERS IN BOWEL SYNDROME")
INFLAMMATION MARKERS IN BOWEL SYNDROME29,99 €![Genetic, Haematologic and Inflammatory Markers in Prostate Cancer]( "Genetic, Haematologic and Inflammatory Markers in Prostate Cancer")
Genetic, Haematologic and Inflammatory Markers in Prostate Cancer25,99 €
The incidence of Crohn's disease (CD) and ulcerative colitis (UC) is increasing, but differentiating between them is often difficult. Anti- Saccharomyces cerevisiae mannan antibodies (ASCA), perinuclear antineutrophil cytoplasmic antibodies (pANCA), pancreatic (PAB) and goblet cell autoantibodies (GAB) are serological markers associated with inflammatory bowel disease (IBD). The clinical significance and diagnostic value of these markers are not well defined in different populations.Determining the prevalence of these serological markers in Egyptian population with IBD and assessing the value of pANCA and ASCA as a diagnostic marker in the differentiation between CD and UC is a critical issue. In addition, the combination of these antibodies with PAB and GAB may improve differentiation between IBD subtypes.